Dados B3 › NORD3 × GGBR4
NORD3 × GGBR4
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | NORD3 | GGBR4 | year |
|---|---|---|---|
| ROE | — | 2.5% | no year where both have it |
| ROIC | — | 3.4% | no year where both have it |
| ROA | -63.4% | 1.7% | 2025 |
| Gross margin | 90.8% | 11.4% | 2025 |
| EBIT margin | -184.8%! | 5.4% | 2025 |
| Net margin | -446.0% | 2.0% | 2025 |
| Net debt/EBITDA | — | 1.05x | no year where both have it |
| Current ratio | 0.00x | 2.89x | 2025 |
| Revenue growth (1y) | 8.0% | 4.2% | 2025 |
| Revenue growth (5y CAGR) | 11.0% | 9.8% | 2025 |
| Piotroski F-Score | 3/9 | 5/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | NORD3 | GGBR4 | year |
|---|---|---|---|
| P/E | -0.00x | 30.77x | 2025 |
| P/B | — | 0.80x | 2025 |
| EV/EBITDA | — | 6.80x | 2025 |
| FCF yield | — | 2.7% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 05:44 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 05:44 UTC. If this does not match /saude, you are reading a cached copy.